跳至主要内容
临床试验/KCT0007444
KCT0007444尚未招募未知

Efficacy comparison of 7 and 14-days P-CAB based bismuth-containing quadruple regimen with PPI based bismuth-containing quadruple regimen for Helicobacter pylori infection: open-label, randomized controlled trial

Hallym University Medical Center0 个研究点目标入组 366 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
366

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 85(Year)(—)
性别
All

入选标准

  • 1) age >19 or <85 years
  • 2) patients who tested positive for H. pylori
  • 3) patients who had endoscopically confirmed gastric ulcer, duodenal ulcer (including scar), low grade gastric MALT lymphoma, gastric dysplasia or early gastric cancer, Atrophic gastritis, H. pylori gastritis
  • 4) patients who will be compliant to study procedures
  • 5) patients who have signed the Informed Consent
  • 6) patients who have agreed to use acceptable contraception methods

排除标准

  • 1) previous H. pylori eradication therapy
  • 2) patients with severe concurrent disease or malignancy
  • 3) history of gastrectomy
  • 4) patients who used PPI, H2 blocker, Histamine H2-receptor antagonists 14 days prior to trial
  • 5) patients who have taken bismuth-containing drugs or antibiotics within 28 days prior to trial
  • 6) pregnant or lactating women
  • 7) liver cirrhosis or Hepatic insufficiency
  • 8) renal insufficiency
  • 9) other organ cancer within 5 years
  • 10) history of stomach operation
  • 11) addiction to alcohol or illicit and recreational drugs
  • 12) a person who taking HIV protease inhibitors (atazanavir, nelfinavir) or a drug containing rilpivirine
  • 13) patients receiving statin therapy

研究者

相似试验